Literature DB >> 26334194

Report of two Cases with Metastasis in Lymph NodesAlong the Posterior Leaf of the Bursa Omentalis at the Area of the Pancreatic Body, an Area not Routinely Examined in Standard Gastrectomy Plus Bursectomy for Advanced Gastric Cancer.

Konstantinos Blouhos1, Konstantinos A Boulas2, Konstantinos Tsalis3, Nikolaos Barettas1, Michail Aftzoglou1, Anestis Hatzigeorgiadis1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26334194     DOI: 10.1007/s12029-015-9756-6

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  24 in total

Review 1.  Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer?

Authors:  Yasuhiro Kodera; Daisuke Kobayashi; Chie Tanaka; Michitaka Fujiwara
Journal:  Surg Today       Date:  2014-11-01       Impact factor: 2.549

2.  Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual.

Authors:  S Eva Singletary; Frederick L Greene; Leslie H Sobin
Journal:  Cancer       Date:  2003-12-15       Impact factor: 6.860

3.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

4.  Right-sided bursectomy as an access plane for aesthetic resection of the posterior leaf of the lesser sac from the head of the pancreas en block with the No. 6 and 14v lymph nodes in advanced lower third gastric cancer.

Authors:  Konstantinos Blouhos; Konstantinos Andreas Boulas; Konstantinos Tsalis; Anestis Hatzigeorgiadis
Journal:  Surgery       Date:  2015-02-20       Impact factor: 3.982

5.  [Analysis of risk factors associated with metastasis of lymph node along superior mesenteric vein in patients with gastric cancer].

Authors:  Ruohua Chen; Hao Wang; Meng Wang; Wenxian Guan
Journal:  Zhonghua Wei Chang Wai Ke Za Zhi       Date:  2014-02

6.  Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: an updated meta-analysis of randomized controlled trials.

Authors:  B Xiong; L Ma; Y Cheng; C Zhang
Journal:  Eur J Surg Oncol       Date:  2014-02-25       Impact factor: 4.424

7.  Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.

Authors:  Bang Wool Eom; Jungnam Joo; Young-Woo Kim; Daniel Reim; Ji Yeon Park; Hong Man Yoon; Keun Won Ryu; Jong Yeul Lee; Myeong-Cherl Kook
Journal:  Surgery       Date:  2013-11-25       Impact factor: 3.982

Review 8.  WITHDRAWN: Neoadjuvant chemotherapy versus none for resectable gastric cancer.

Authors:  A W Wu; G W Xu; H Y Wang; J F Ji; J L Tang
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

9.  Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.

Authors:  A Tsuburaya; J Mizusawa; Y Tanaka; N Fukushima; A Nashimoto; M Sasako
Journal:  Br J Surg       Date:  2014-03-25       Impact factor: 6.939

10.  A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis.

Authors:  Yan Wang; Yi-yi Yu; Wei Li; Yi Feng; Jun Hou; Yuan Ji; Yi-hong Sun; Kun-tang Shen; Zhen-bin Shen; Xin-yu Qin; Tian-shu Liu
Journal:  Cancer Chemother Pharmacol       Date:  2014-04-21       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.